The Atherogenic Index of Plasma as a Novel Marker of Critical Multivessel Disease in Non-ST-Elevation Myocardial Infarction.
AIP was independently associated with the presence of critical MVD in patients with NSTEMI. Given its simplicity, affordability, and accessibility, AIP may serve as a practical indicator of atherogenic burden and assist in identifying patients who are more likely to have multivessel coronary involvement.
Authors
- Erhan Saraçoğlu (ORCID: https://orcid.org/0000-0003-3797-512X)
- Kürşat Akbuğa (ORCID: https://orcid.org/0000-0002-7716-6143)
- Alperen Taş (ORCID: https://orcid.org/0000-0002-1696-7449)
- Vedat Hekimsoy (ORCID: https://orcid.org/0000-0003-3542-894X)
- Ali Sezgin (ORCID: https://orcid.org/0000-0003-0139-7962)
- Bülent Özlek
- Veysel Ozan Tanık (ORCID: https://orcid.org/0000-0002-7193-4324)
- Çağatay Tunca (ORCID: https://orcid.org/0000-0001-7111-8450)
Institutions
- Ministry of Health (TR)
- Education Training And Research (US)
- Muğla University (TR)
Publication Details
- Journal
- PubMed
- Published
- 2025-12-12
- DOI
- https://doi.org/10.5543/tkda.2025.41820
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00